Quest Diagnostics Inc. (DGX) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for DGX. 13F holdings as of 2026-06-30.

In 13F filings for the quarter ended June 30, 2026, 1,082 institutions reported holding DGX, with 104.3 million shares worth $22.1 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
Vanguard14,553,517$3.1BINCREASED
BlackRock9,275,411$2.0BINCREASED
State Street5,516,643$1.2BINCREASED
T. Rowe Price5,444,986$1.2BDECREASED
Boston Partners4,744,473$1.0BINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Gary M Pfeiffer (Director)SELL1,203$292K2026-10-26
Mark E Delaney (SVP & Chief Commercial Officer)OTHER25$6K2026-10-21
Timothy L Main (Director)OTHER18$4K2026-10-21
Patrick Plewman (SVP for Diagnostic Services)OTHER41$10K2026-10-21
Wright Lassiter III (Director)OTHER6$1K2026-10-21

Recent Congressional Trades

MemberTypeAmountDate
Ro Khanna (Democrat)PURCHASE$1,001 - $15,0002026-09-04
Carol D. Miller (Republican)SALE$15,001 - $50,0002025-03-10
Carol D. Miller (Republican)SALE$15,001 - $50,0002025-03-09

Full institutional holdings, insider history, and congressional trades for Quest Diagnostics Inc. on SentiSense.